Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours

This publication has 32 references indexed in Scilit:

• Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs
  Journal of Cancer Research and Clinical Oncology, 1999
• Cancer statistics, 1998
  CA: A Cancer Journal for Clinicians, 1998
• Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone
  British Journal of Cancer, 1997
• Synthesis and In Vitro Evaluation of New Potent Antagonists of Growth Hormone-Releasing Hormone (GH-RH)
  Peptides, 1997
• Induction and involvement of endogenous IGF-I in pancreas regeneration after partial pancreatectomy in the dog
  Journal of Endocrinology, 1996
• Inhibition of Growth of Human Osteosarcomas by Antagonists of Growth Hormone-Releasing Hormone
  JNCI: Journal of the National Cancer Institute, 1995
• No standard treatment is available for advanced pancreatic cancer
  European Journal of Cancer, 1995
• A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis
  Nature, 1994
• Hypothalamic hormones
  Anti-Cancer Drugs, 1994
• Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters events that accompany tumor regression
  Cancer, 1990